Abstract
Introduction

!
For many decades, vaccine immunogenicity has been enhanced by formulation with adjuvants. Proteins derived from the host immune system such as cytokines, chemokines and other costimulatory molecules are being evaluated as adjuvants. Such natural immune stimulators can be co-delivered with the vaccine as recombinant proteins. Alternatively, the inclusion of various cytokine genes (including IL-2, IL-12, IL-28 or GM-CSF) has been shown to improve the immunogenicity of DNA vaccines against HIV-1, influenza, hepatitis B virus, hepatitis C virus and cancer (1, 2) . Cytokines can also be fused directly to vaccine antigens, Abs or self-antigens to make chimeric proteins (3-8). Using this method, immune cells that are targeted by the antigen of interest can be simultaneously activated by the incorporated cytokine, allowing selective augmentation of the most desired immune response.
One potential disadvantage of using host proteins in this way is the potential for inducing autoimmune responses, but whether anticytokine responses are induced is often not studied in detail.
HIV-1 recombinant envelope glycoprotein (Env) protein vaccines invariably require adjuvants. Env, the only relevant immunogen for, and target of, neutralizing antibodies (NAbs), has many structural defenses against NAbs, including the presence of hypervariable domains, multiple shielding glycans and the exposure of decoy epitopes on nonfunctional Env forms. Taken together, these factors contribute to the lack of success of HIV-1 Env-based vaccines to date (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . In addition to the intrinsic properties that impede the induction of broadly active NAbs, the half-life of the overall anti-Env Ab response is very short, typically 30-60 d (23, 24) . One explanation may be poor induction of long-lived plasma cells. Of note is that the N-linked oligomannose glycans present on Env can actively suppress immune cell functions (25) (26) (27) (28) .
Attempts to improve the immunogenicity of HIV-1 Env include co-delivery with molecular adjuvants (1) . Alternatively, Env proteins, in most cases monomeric gp120, have been fused directly to immune modulators, including IFN-γ, TNF-α, Flt-3 ligand, CTLA4, C3d and a proliferation inducing ligand (APRIL) to make chimeric molecules (6, [29] [30] [31] [32] [33] . We have shown that fusing Env trimers to costimulatory molecules such as CD40L and APRIL that facilitate B cell help can be beneficial to Env immunogenicity (5, 6). Furthermore, replacing Env variable loops 1 and 2 (V1V2) with GM-CSF increased both anti-gp120 binding Ab titers and T cell responses in mice (34, 35) , while replacing the same loops with Page !IL-21 enhanced Ig secretion and the formation of human plasmablast-like B cells in vitro (36) .
Both GM-CSF and IL-21 cytokines have a good safety profile in clinical studies. For example, GM-CSF is being used as an adjuvant in several Phase I/II trials against a variety of tumors (37, 38) , and IL-21 has been tested against metastatic melanoma and renal cancer (39) (40) (41) .
In this study, we investigated whether trimeric HIV-1 Env proteins with GM-CSF or IL-21 cytokines incorporated into the V1V2 domain or fused to the C-terminus (Ct) would increase the induction of anti-Env Ab responses in vivo. We also assessed whether autoantibodies were raised against the cytokine component. The outcome was that we saw at best only a modest improvement in anti-Env responses, accompanied by strong anticytokine responses that were independent of the design of the Env-cytokine chimeric protein.
Materials and methods
!
Constructs
All constructs in this study were based on the codon-optimized stabilized HIV-1 JR-FL (subtype B) SOSIP.R6-IZ-H8 gp140 sequence (Envwt) that has been described in detail elsewhere (10, 20, (42) (43) (44) . Despite the presence of the SOSIP mutations, these trimers are not native-like as we recently published for BG505 SOSIP.664 gp140 (45) (46) (47) . The constructs used in this study were based on the earlier generation JR-FL SOSIP.R6 and the addition of Cterminal protein domains such as a GCN4-based isoleucine zipper trimerization domain (IZ) or cytokine domains render them uncleavable (5, 44), and uncleaved and cleaved gp140 trimers are antigenically and structurally different (48, 49) . Amino acid numbering is based on the HXB2 gp160 sequence, according to convention. A list of constructs used in this study is provided in Supplementary Table I . Rabbit IL-21 (rIL-21) was amplified from rabbit PBMCs, using the Expand PCR system according to the manufacturer's instructions (Roche, Mannheim, Germany). The PCR was performed with sense and antisense primers (5'rIL-21
[5'-CATCTGTCTGATGGTCATCTTCTT-3'] and 3'rIL-21 [5'TTCAAGGAGATGCTG ATGAATC-3']). The PCR products were sequenced. Codon-optimized genes encoding rabbit GM-CSF (rGM-CSF), mouse IL-21 (mIL-21) or rIL-21 flanked by HindIII and BmgBI restriction sites, were synthesized (Mr. Gene, Regensburg, Germany). The V1V2 domains of Env were substituted by the sequences coding for GM-CSF or IL-21 using the HindIII and BmgBI restriction sites to generate EnvrGM-CSF, EnvmIL-21 and EnvrIL-21, similar to generation Page !of Env-human-GM-CSF (EnvhGM-CSF), Env-mouse-GM-CSF (EnvmGM-CSF) and Env-human-IL-21 (EnvhIL-21) that we described previously (35, 36) . Codon-optimized genes of human G M -C S F ( h G M -C S F ) , r G M -C S F o r r I L -2 1 i n c l u d i n g a l i n k e r s e q u e n c e (GGCGGCCGCGGGGGAGGGGGGTCTGGAGGAGGC, which encodes the peptide sequence GGRGGGGSGGG) flanked by NotI and SfuI restriction sites were synthesized (Mr. Gene) and cloned at the Ct of SOSIP.R6-IZ (EnvhGM-CSF-Ct, EnvrGM-CSF-Ct and EnvrIL-21-Ct). To generate the His-tagged-cytokine vectors, rabbit or mouse GM-CSF or IL-21 flanked by NotI and SfuI restriction sites were cloned at the Ct of a His-tag (8 x histidine). The sequences of all constructs were verified by sequencing. 
!
Cells and transfections
293T cells were maintained in DMEM (Invitrogen, Breda, the Netherlands) supplemented with 10% heat-inactivated FCS (HyClone, Perbio, Etten-Leur, the Netherlands), MEM nonessential amino acids (0.1 mM; Invitrogen) and penicillin/streptomycin (both at 100 U/ ml). The cells were transiently transfected with plasmids expressing recombinant Env using the Lipofectamine reagent according to the manufacturer's instructions (PAA, Pasching, Austria). Env-containing supernatants were harvested 48 h after transfection and frozen in aliquots. TF-1 cells (50), a gift from P. Coffer, were cultured in RPMI 1640 (Invitrogen) with 10% FCS, supplemented with 25 U/ml rhGM-CSF (Schering-Plough). Ig secretion by B cells was quantified as described previously (36) .
! ! !
SDS-PAGE, native PAGE and western blotting
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting were performed as previously described (44) . Env was detected using mAb PA1 (0.2 µg/ml) and a 1:5000 diluted secondary HRP-labeled goat anti-mouse IgG (Kirkegaard & Perry Laboratories, Maryland, USA) followed by the Western Lightning ECL system (PerkinElmer, Groningen, the Netherlands). Native PAGE was carried out as reported elsewhere (35).
!
Anti-Env ELISA
Anti-gp120 Ab titers were measured by D7324-capture ELISA as described previously (35, 44, 47) . Reactivity of Env proteins with mAbs or receptor mimics were measured by antitrimer ELISA as described previously using Ni-NTA HisSorb 96-well plates (Qiagen, Venlo, the Netherlands)(10, [34] [35] [36] 47) . Equal input levels of proteins were verified by SDS-PAGE followed by western blot analysis. All ELISA data are representative of at least three independent experiments, each using Env proteins derived from independent transfections. Endpoint titers were calculated using GraphPad Prism (version 5.03) by determining the serum dilution at which the optical density (OD450) was three times above the background OD450 signal (without animal sera).
!
Anticytokine ELISA
The anticytokine ELISA was performed as previously described for the anti-trimer ELISA (10, [34] [35] [36] 47) . The wells were coated with supernatants containing His-tagged cytokines (Supplementary Table I ) or mock media (or Envwt for comparative purposes) and the plates were washed twice with Tris-buffered saline (TBS). Heat-inactivated (30 min, 56°C) rabbit or mouse sera were serially diluted in TBS containing 20% sheep serum (Biotrading, Mijdrecht, Netherlands) and 2% skim milk powder, and incubated for 2 h. The subsequent steps were as previously described for the anti-Env ELISA (44).
!
Immunoprecipitation assays
Immunoprecipitation assays were performed as previously described (5, 6), using PA1, 2G12, b12, VRC01, CD4-IgG2, 2F5, or 48d at final concentrations of 4 µg/ml and, when appropriate, also sCD4 at 10 µg/ml. The immunoprecipitates were analyzed by SDS-PAGE followed by western blotting with mAb PA1. (51, 52) . All sera were heat-inactivated (30 min, 56°C) before use. Neutralization assays were performed using the tier 1A virus SF162 and the tier 2 virus JR-FL, which is the homologous strain to the vaccine antigen. Single cycle infection and inhibition experiments were performed as described previously, using 3-fold serially diluted sera, with each sample tested in duplicate against each virus (10, 53). The percentage of neutralization was determined by measuring the reduction of the luciferase signal by each serum dilution compared to the values measured in the absence of serum (defined as 100%). The 50% (midpoint) neutralization titers were determined using GraphPad Prism (version 5.03).
!
GM-CSF activity assay
Myeloid leukemia TF-1 cells (5.0 x 10 4 ) (50) were seeded in a 96-well plate before addition of serially diluted supernatants from mock, Envwt, EnvhGM-CSF or EnvhGM-CSF-Ct transfected 293T cells. rhGM-CSF (50 U/ml) diluted in mock supernatant was used as positive control.
Each sample was tested in triplicate wells in at least three independent experiments using proteins derived from separate transfections. The cells were harvested on day five and the percentage of living cells was determined by FACS flow cytometry.
!
Gene gun DNA immunizations of animals
Plasmids encoding Env proteins were amplified using DH5α cells and isolated using an EndoFree Plasmid Giga kit (Qiagen). New Zealand White rabbits (6 or 12/group) were immunized at weeks 0, 2, 4 and 8 with 125 µg of endotoxin-free DNA via the abdominal dermis using gene gun technology (54) . Blood samples were obtained at weeks 0, 2, 4, 6 and 8, with a final bleed at week 10. Outbred NMRI mice (4 or 5/group) were immunized at weeks 0, 2, 4, and 6 with 20 µg of DNA in the abdominal dermis using the same gene gun method. Blood samples were obtained from weeks 0, 2, 4, and 6, with a final bleed at week 6 or 8. All protocols dealing with animal manipulations were in accordance with guidelines published by FELASA (Federation of European Animal Science Association) and GV-SOLAS (German Society of Laboratory Animal Science) and were reviewed by the Harlan, MFD Diagnostics, or Davids Biotechnologie Animal Care Committees, as appropriate.
Results
!
Generation and characterization of EnvrGM-CSF and EnvrIL-21
We have previously described the insertion of various cytokines into the V1V2 domain of Envwt (34) (35) (36) . Here, we used the same approach with the cytokines GM-CSF and IL-21, using rabbit sequences, to generate the EnvrGM-CSF and EnvrIL-21 chimeric proteins for in vivo studies in rabbits (Fig. 1A) . We note that during the course of these studies a better soluble mimic of the native Env spike was identified (BG505 SOSIP.664 gp140), but we did not use it here (45) (46) (47) . Both chimeric EnvrGM-CSF and EnvrIL-21 proteins were expressed by transient transfection of 293T cells, EnvrGM-CSF expression was similar to Envwt whereas EnvrIL-21 was produced less efficiently (see Supplementary Fig. 1A ) (36) . The antigenic structures of EnvrGM-CSF and EnvrIL-21 were analyzed using an anti-trimer ELISA and were found to be similar to those of EnvhGM-CSF, EnvmGM-CSF, EnvhIL-21 and EnvmIL-21 ( Supplementary Fig. 1B ) (34) (35) (36) .
To test whether the rIL-21 moiety embedded in the V1V2 domain was functional, we (Fig. 1B and 1C) . We also wished to examine the function of rGM-CSF embedded in the V1V2 domain of Env. Unfortunately, the TF-1 cell-based GM-CSF activity assay (50) that we used previously to show that hGM-CSF embedded in V1V2 was functional (35), was not sensitive to rGM-CSF, probably because the human GM-CSF receptor is not cross-reactive with rGM-CSF, and other reagents to validate whether rGM-CSF is functional are not available.
! ! !
Rabbit immunizations with Envwt, EnvrGM-CSF and EnvrIL-21
We immunized rabbits with DNA encoding the Envwt (n=6) or EnvrGM-CSF (n=6) proteins using a gene gun. In a separate, but similar experiment we compared Envwt (n=12) with EnvrIL-21 (n=12). The rabbits were immunized at weeks 0, 2, 4 and 8 as described previously (6), and bled at weeks 0, 2, 4, 6, 8 and 10 for serology studies. When the anti-gp120 midpoint IgG titers in week-10 sera were measured by ELISA, the response to EnvrGM-CSF and EnvrIL-21
were slightly lower than to Envwt. Hence, the inserted cytokines had no beneficial effect on the anti-Env response ( Fig. 2A and 2B) . The neutralization capacity of the week-10 sera was Page ! tested in a single-cycle assay using Env-pseudotyped viruses and TZM-bl reporter cells (53) .
None of the test sera neutralized the resistant (tier 2) virus JR-FL (56, 57) , and the responses against the highly sensitive (tier 1A) virus SF162 were weak, inconsistent, and did not differ among the test groups (Tables I and II) . Thus, there was no evidence that the embedded cytokines conferred an immunological benefit on the humoral response.
Induction of anticytokine responses in rabbits immunized with EnvrGM-CSF or EnvrIL-21
One potential concern with using self-molecules as adjuvants is the potential of inducing autoantibodies. We therefore quantified the rabbit anticytokine Ab responses induced by the above chimeric Env proteins, using an ELISA in which His-tagged versions of Env, GM-CSF or IL-21 were immobilized on Ni-NTA coated plates (see Materials and methods). Rabbits immunized with EnvrGM-CSF induced Abs against rGM-CSF but, as expected, the sera from the Page ! 120 Envwt group lacked these Abs ( Fig. 2C and 2D) . A similar result was obtained for the EnvrIL-21-immunized rabbits, which induced Abs to the IL-21 cytokine insert (Fig. 2E and 2F ).
We also determined the Ab responses to the Env components using anti-trimer ELISA, but again found no improvement in anti-Env Ab levels in the Env-chimera immunized rabbits, compared to Envwt (Fig. 2G and 2H) . The anti-GM-CSF responses were comparable to the anti-Env responses, but those against anti-IL-21 were ~10-fold lower compared to the antiEnv responses (and ~10-fold lower compared to the anti-GM-CSF responses). Overall, we conclude that the embedded rIL-21 or rGM-CSF domains were strongly immunogenic in that they induced autoantibodies.
! !
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Induction anticytokine responses to EnvmGM-CSF and EnvmIL-21 molecules in mice
To test whether the anticytokine responses were unique to rabbits, we immunized mice with DNA encoding Envwt and EnvmIL-21, the latter generated by the same strategy used for the human and rabbit Env-IL-21 chimeras (35, 36) . In addition, we tested sera from a previous mouse immunization experiment that had compared the immunogenicity of Envwt and EnvmGM-CSF (35). The expression, antigenicity and cytokine activity of EnvmGM-CSF and EnvmIL-21 were similar to their human and rabbit counterparts (data not shown and (35, 36) ).
The mice were immunized with Envwt and EnvmIL-21 DNA at weeks 0, 2 and 4, and sacrificed at week 6. The week-6 sera from mice immunized with Envwt (n=4) and EnvmIL-21 (n=4), and the historic week-8 sera from mice immunized with Envwt (n=5) and EnvmGM-CSF (n=5) (35), were tested for the presence of anti-mIL-21 and anti-mGM-CSF autoantibodies in similar titration experiments as those shown in Fig. 2C-2F (Fig. 3A and 3B ). We note that the anti-Env and anticytokine Ab levels were lower in the mice than in the rabbits. This probably reflects differences in study regimen and duration. There were no anticytokine responses to mGM-CSF or mIL-21 in any of the Envwt recipients, whereas anti-mGM-CSF and antimIL-21 autoantibodies were detectable in the EnvmGM-CSF and EnvmIL-21 immunized mice, respectively ( Fig. 3A and 3B) . The anti-gp120 and anti-trimer IgG Ab titers were significantly (p=0.027) higher in the EnvmGM-CSF recipients than in Envwt (Fig. 3A and (35) ), but this was not the case for EnvmIL-21 recipients (Fig. 3B and data not shown) . Thus, both mice and rabbits generate autoantibodies against GM-CSF and IL-21 when these cytokines are embedded within the V1V2 domain of trimeric HIV-1 Env proteins.
! ! !
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Generation and functionality of chimeric HIV-1 Env molecules with GM-CSF or IL-21 fused at the C-terminus
We reasoned that the embedding of a self-molecule (i.e. the cytokine) within the body of a different molecule (i.e. Env) might exacerbate the generation of autoantibodies. To investigate whether the location of the cytokine molecule within the chimera is a relevant factor, we fused the rabbit GM-CSF and IL-21 molecules to the Ct of the Env trimer, to generate the chimeric EnvrGM-CSF-Ct and EnvrIL-21-Ct proteins (Fig. 4A) . These constructs are analogous to the EnvAPRIL and EnvCD40L molecules we have previously studied (5, 6). To minimize interactions between the Env and the cytokine, we inserted a long spacer between them (amino acid sequence GGRGGGGSGGG). The added cytokine sequences did not affect protein expression, and both EnvrGM-CSF-Ct and EnvrIL-21-Ct formed predominantly trimers, similarly to Envwt (Supplementary Fig. 2A ). Because these constructs do not have a His-tag and cannot be used in Ni-NTA ELISA (Supplementary Table I), the antigenic structure and folding of EnvrGM-CSF-Ct and EnvrIL-21-Ct was evaluated by performing immunoprecipitation experiments, with conformational NAbs or a CD4 receptor mimic as described previously (6).
Env antigenicity was not influenced by the presence of cytokine molecules at the Ct ( Supplementary Fig. 2B-2D) . Furthermore, the cytokine moieties retained their activities, as EnvhGM-CSF-Ct was active on TF-1 cells that require GM-CSF for proliferation (Supplementary 
Induction of anticytokine responses by the EnvrGM-CSF-Ct and EnvrIL-21-Ct chimeras
Groups of 6 rabbits were immunized with DNA encoding Envwt, EnvrGM-CSF-Ct or EnvrIL-21-Ct using the same protocol as before. Anti-rGM-CSF and anti-rIL-21 autoantibodies were induced in the EnvrGM-CSF-Ct and EnvrIL-21-Ct recipients, but not in rabbits immunized with Envwt (Fig. 4B) . The anti-IL-21 endpoint titers were ~15-fold lower compared to the anti-GM-CSF titers. The anti-GM-CSF endpoint titers induced were slightly higher compared to the titers induced by GM-CSF embedded within the V1V2 of Env (compare Fig. 2G with Fig.   4B ), whereas no such a trend was observed for IL-21 (Fig. 2H and 4B ). There was no improvement in the anti-trimer or anti-gp120 IgG responses in EnvrGM-CSF-Ct and EnvrIL-21-Ct immunized rabbits, compared to Envwt (Fig. 4C and data not shown) . When the rabbit sera (week 10) were tested for SF162 and JR-FL virus neutralization, no differences were found between the three groups (data not shown). In summary, autoantibodies were raised to GM-CSF and IL-21 irrespective of where the cytokine was located in the chimeric Env protein (i.e., within the V1V2 domain or at the Ct).
Discussion
!
Adjuvants, including ones based on costimulatory self-molecules such as cytokines, can improve vaccine immunogenicity by various mechanisms, including by activating relevant immune cells. The use of costimulatory self-molecules may also help skew the immune response into the desired direction (i.e., humoral versus cellular responses). However, a disadvantage of this approach is that undesired autoimmune responses may be generated against the self-molecule when it is presented in a non-natural context. Although the beneficial effects of including cytokines in vaccines, particularly DNA vaccines, are being studied extensively, whether autoimmunity arises is rarely investigated. In this study, we examined, in both mice and rabbits, whether chimeric cytokine-Env molecules induced autoimmune responses to the cytokine moiety, and whether the location of the cytokine mattered. We found that substantial autoantibody responses were raised against GM-CSF and IL-21, when the cytokine was either embedded in the body of the Env protein (i.e. within the V1V2 loop structure) or attached to the Ct (via a flexible linker sequence). We have not evaluated Ct fused cytokines in mice, but we would expect similar results. Whether induction of autoantibodies accounts for the failure of the cytokines to boost the Ab responses to the Env remains to be determined. However, we note that EnvmGM-CSF did induce stronger anti-gp120 Ab and T cell responses in mice, indicating that the presence of anti-GM-CSF Abs does not necessarily abolish the adjuvant activity of the embedded cytokine (35).
Autoantibodies against cytokines may have multiple adverse effects. One example involves some formulations of recombinant human erythropoietin used to treat renal anemia.
Several patients developed more severe anemia, which was attributed to the unwanted induction of NAbs against erythropoietin (58) . Autoantibodies can be induced when recombinant IFN-α, IFN-β and GM-CSF are repeatedly administered (59) (60) (61) . In a clinical trial neutropenic cancer patients were treated with rhGM-CSF. Although the patients developed anti-GM-CSF Abs no adverse effects or abnormal hematologic conditions were observed (62) . Furthermore, in a rabbit immunization study, DNA coimmunization with murine GM-CSF enhanced the protective immunity to the given antigen although anti-GM-CSF Abs were detected (63) . An autoantibody response also arose in a subset of patients with metastatic malignant melanoma and renal cell carcinoma who were treated with rhIL-21, but the neutralizing anti-rhIL-21 Abs were not associated with any specific adverse effects (40) .
Abs to certain cytokines may be involved in various immune-inflammatory diseases such as rheumatoid arthritis, and also certain cancers (64) (65) (66) (67) (68) , while anti-GM-CSF Abs have been correlated with the severity of pulmonary alveolar proteinosis (69) . Abs targeting cytokines, including GM-CSF, IL-2, IL-6, IL-10, IFN-γ and IFN-α, can be detected in the sera of healthy individuals, implying that they are not necessarily harmful (59, (70) (71) (72) (73) (74) . In some cases these Abs have been suggested to have a protective role against some disease conditions (75, 76), by beneficially influencing cytokine localization, half-life and activity (59, 77, 78) . We did not observe cytokine-related adverse effects in the animals from this study.
We note that the soluble Env proteins used in this study are uncleaved gp140s that cannot adopt a native-like structure (5, 6). The BG505 SOSIP.664 gp140 protein, which is a close antigenic and structural mimic of the native spike (45) (46) (47) was not available when this study was initiated. Cleaved and uncleaved soluble trimers are structurally and antigenically very dissimilar, and only cleaved trimers resemble the functional Env spikes found on virions (45) (46) (47) 49) . Whether fusing costimulatory molecules to cleaved, native-like SOSIP gp140 trimers would yield a different outcome remains to be determined. It is possible that the splayed-out nature of uncleaved trimers and their increased vulnerability to proteases (48, 49) might exacerbate the induction of autoantibodies against the cytokine moiety. The incorporation of cytokines in the V1V2 domain of cleaved native-like SOSIP trimers might be problematic because the wild-type V1V2 domains form and stabilize the trimer apex (45, 46) . 
